{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:32:58Z","timestamp":1787790778729,"version":"build-2784847793"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.micpath.2021.104889","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T18:44:50Z","timestamp":1618771490000},"page":"104889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The relationship between biofilm formation and mortality in patients with Candida tropicalis candidemia"],"prefix":"10.1016","volume":"155","author":[{"given":"Elahe","family":"Sasani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Khodavaisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sassan","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Yadegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104889_bib1","first-page":"1","article-title":"Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients: non-albicans candidemia in cancer patients","volume":"6","author":"Wu","year":"2017","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.micpath.2021.104889_bib2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/myc.13053","article-title":"Epidemiological features of nosocomial candidaemia in neonates, infants and children: a multicentre study in Iran","volume":"63","author":"Ahangarkani","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.micpath.2021.104889_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/myc.12695","article-title":"Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil","volume":"61","author":"S Canela","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.micpath.2021.104889_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0125149","article-title":"The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards","volume":"10","author":"De Rosa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2021.104889_bib5","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1469-0691.2010.03338.x","article-title":"Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital","volume":"17","author":"Munoz","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.micpath.2021.104889_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11046-019-00370-7","article-title":"In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species","volume":"184","author":"Mahmoudi","year":"2019","journal-title":"Mycopathologia"},{"key":"10.1016\/j.micpath.2021.104889_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mycmed.2017.02.007","article-title":"Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis","volume":"27","author":"Vaezi","year":"2017","journal-title":"J. Mycol. Med."},{"key":"10.1016\/j.micpath.2021.104889_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2147\/JMDH.S252371","article-title":"Fungal Isolates of the Respiratory Tract in Symptomatic Patients Hospitalized in Pulmonary Units: A Mycological and Molecular Epidemiologic Study","volume":"13","author":"Rafat","year":"2020","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.micpath.2021.104889_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1590\/S0074-02762013000300005","article-title":"Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil","volume":"108","author":"Wille","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2021.104889_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0127534","article-title":"Clinical and therapeutic aspects of candidemia: a five year single centre study","volume":"10","author":"Bassetti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2021.104889_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","article-title":"A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.micpath.2021.104889_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","article-title":"Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period","volume":"40","author":"Colombo","year":"2014","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.micpath.2021.104889_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","article-title":"Impact of therapeutic strategies on the prognosis of candidemia in the ICU","volume":"42","author":"Puig-Asensio","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.micpath.2021.104889_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eimc.2016.04.003","article-title":"Assessment of biofilm production in Candida isolates according to species and origin of infection","volume":"35","author":"Guembe","year":"2017","journal-title":"Enferm. Infecc. Microbiol. Cl\u00edn."},{"key":"10.1016\/j.micpath.2021.104889_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.5301\/ijao.5000028","article-title":"Biofilm formation of Candida spp. isolates from patients at a cardiothoracic intensive care unit","volume":"34","author":"Tobudic","year":"2011","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.micpath.2021.104889_bib16","first-page":"1","article-title":"Pathogenesis of Candida albicans biofilm. FEMS pathogens and disease","volume":"74","author":"Tsui","year":"2016","journal-title":"FEMS Pathogens Dis."},{"key":"10.1016\/j.micpath.2021.104889_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mycmed.2019.02.003","article-title":"Comparison of biofilm-producing ability of clinical isolates of Candida parapsilosis species complex","volume":"29","author":"Modiri","year":"2019","journal-title":"J. Mycol. Med."},{"key":"10.1016\/j.micpath.2021.104889_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1099\/jmm.0.000207","article-title":"In vitro biofilm production of Candida bloodstream isolates: any association with clinical characteristics?","volume":"65","author":"Pongr\u00e1cz","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2021.104889_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmi.2015.09.018","article-title":"Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-scotland, 2012\u20132013","volume":"22","author":"Rajendran","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2021.104889_bib20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JCM.40.4.1244-1248.2002","article-title":"Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources","volume":"40","author":"Shin","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2021.104889_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033705","article-title":"Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital","volume":"7","author":"Tumbarello","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104889_bib22","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/JCM.00131-07","article-title":"Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia","volume":"45","author":"Tumbarello","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2021.104889_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.mimet.2011.05.019","article-title":"Biofilm formation by five species of Candida on three clinical materials","volume":"86","author":"Estivill","year":"2011","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.micpath.2021.104889_bib24","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104889_bib25","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","article-title":"Standardized method for in vitro antifungal susceptibility testing of Candida albicansbiofilms","volume":"45","author":"Ramage","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104889_bib26","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogenCandida albicans: development, architecture, and drug resistance","volume":"183","author":"Chandra","year":"2001","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2021.104889_bib27","doi-asserted-by":"crossref","first-page":"54881","DOI":"10.1074\/jbc.M411374200","article-title":"A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence","volume":"279","author":"Vuong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2021.104889_bib28","first-page":"35","article-title":"Antifungal susceptibility pattern and biofilm-related genes expression in planktonic and biofilm cells of Candida parapsilosis species complex","volume":"5","author":"Modiri","year":"2019","journal-title":"Curr. Med. Mycol."},{"key":"10.1016\/j.micpath.2021.104889_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1567-1364.2006.00117.x","article-title":"Candida biofilms on implanted biomaterials: a clinically significant problem","volume":"6","author":"Ramage","year":"2006","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.micpath.2021.104889_bib30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/dkf049","article-title":"Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms","volume":"49","author":"Ramage","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.104889_bib31","first-page":"163","article-title":"Characteristics of biofilm formation by Candida albicans","volume":"18","author":"Ramage","year":"2001","journal-title":"Rev. Iberoam. De. Micol."},{"key":"10.1016\/j.micpath.2021.104889_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(07)60002-4","article-title":"epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England","volume":"65","author":"Pratt","year":"2007","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.micpath.2021.104889_bib33","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/mmy\/myz124","article-title":"Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates","volume":"58","author":"Arastehfar","year":"2020","journal-title":"Med. Mycol. J."},{"key":"10.1016\/j.micpath.2021.104889_bib34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11046-016-0050-3","article-title":"The role of UPC2 gene in azole-resistant Candida tropicalis","volume":"181","author":"Jiang","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.micpath.2021.104889_bib35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jac\/dks481","article-title":"Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China","volume":"68","author":"Jiang","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.104889_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.diagmicrobio.2018.09.007","article-title":"YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries","volume":"93","author":"Arastehfar","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104889_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fcimb.2019.00021","article-title":"Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA sequencing for a wide range of clinically isolated yeast species: improved identification by combining 21-Plex PCR and API 20C AUX as an alternative strategy for developing countries","volume":"9","author":"Arastehfar","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2021.104889_bib38","first-page":"1","article-title":"An improved crystal violet assay for biofilm quantification in 96-well microtitre plate","author":"Shukla","year":"2017","journal-title":"Biorxiv"},{"key":"10.1016\/j.micpath.2021.104889_bib39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1159\/000484718","article-title":"The effect of nutritive and non-nutritive sweeteners on the growth, adhesion, and biofilm formation of Candida albicans and Candida tropicalis","volume":"26","author":"Weerasekera","year":"2017","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.micpath.2021.104889_bib40","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard","author":"Wayne","year":"2008"},{"key":"10.1016\/j.micpath.2021.104889_bib41","unstructured":"P.A. Wayne. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilutionn Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement M27-S4. 2012."},{"key":"10.1016\/j.micpath.2021.104889_bib42","series-title":"Epidemiological Cutoff Values for Antifungal Susceptibility Testing","article-title":"CLSI Supplement M59","author":"Wayne","year":"2018"},{"key":"10.1016\/j.micpath.2021.104889_bib43","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.micpath.2021.104889_bib44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000504095","article-title":"Clinical characteristics and antifungal susceptibility of Candida nivariensis from vulvovaginal candidiasis. Gynecologic and obstetric investigation","volume":"85","author":"Shi","year":"2020","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.micpath.2021.104889_bib45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mycmed.2019.08.001","article-title":"Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures","volume":"29","author":"Sriphannam","year":"2019","journal-title":"J. Mycol. Med."},{"key":"10.1016\/j.micpath.2021.104889_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11046-009-9246-0","article-title":"Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients","volume":"169","author":"Negri","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1016\/j.micpath.2021.104889_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11046-015-9964-4","article-title":"Candida tropicalis biofilms: biomass, metabolic activity and secreted aspartyl proteinase production","volume":"181","author":"Negri","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.micpath.2021.104889_bib48","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cmi.2018.01.022","article-title":"Is biofilm production a prognostic marker in adults with candidaemia?","volume":"24","author":"Mu\u00f1oz","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2021.104889_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.riam.2017.01.005","article-title":"Association between Candida biofilm-forming bloodstream isolates and the clinical evolution in patients with candidemia: an observational nine-year single center study in Mexico","volume":"35","author":"Trevi\u00f1o-Rangel","year":"2018","journal-title":"Rev. Iberoam. De. Micol."},{"key":"10.1016\/j.micpath.2021.104889_bib50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/myc.13049","article-title":"Candida biofilm production is associated with higher mortality in patients with candidaemia","volume":"63","author":"Vit\u00e1lis","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.micpath.2021.104889_bib51","doi-asserted-by":"crossref","first-page":"780","DOI":"10.5301\/ijao.5000170","article-title":"Antifungal activity against Candida biofilms","volume":"35","author":"I\u00f1igo","year":"2012","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.micpath.2021.104889_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3201\/eid1001.030119","article-title":"Fungal biofilms and drug resistance","volume":"10","author":"Jabra-Rizk","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104889_bib53","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1128\/AAC.01237-06","article-title":"Role for cell density in antifungal drug resistance in Candida albicans biofilms","volume":"51","author":"Perumal","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104889_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","article-title":"Mechanisms of biofilm resistance to antimicrobial agents","volume":"9","author":"Mah","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2021.104889_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/13693786.2010.530032","article-title":"Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex","volume":"49","author":"Melo","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.micpath.2021.104889_bib56","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1128\/AAC.39.9.2128","article-title":"Resistance of Candida albicans biofilms to antifungal agents in vitro","volume":"39","author":"Hawser","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104889_bib57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11046-016-0023-6","article-title":"Effect of voriconazole on Candida tropicalis biofilms: relation with ERG genes expression","volume":"181","author":"Fernandes","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.micpath.2021.104889_bib58","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1128\/IAI.71.8.4333-4340.2003","article-title":"Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols","volume":"71","author":"Mukherjee","year":"2003","journal-title":"Infect. Immun."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:33:55Z","timestamp":1760110435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":58,"alternative-id":["S0882401021001613"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104889","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between biofilm formation and mortality in patients with Candida tropicalis candidemia","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104889"}}